#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-small cell lung cancer metastatic Hormone-dependent prostate cancer Plasma cell myeloma refractory Lip and/or oral cavity cancer Myelin oligodendrocyte glycoprotein antibody-associated disease T-cell type acute leukaemia Palmar-plantar erythrodysaesthesia syndrome Pemphigoid HER2 mutant non-small cell lung cancer Endometrial cancer recurrent Hypersomnia Osteosarcoma metastatic Small cell lung cancer limited stage Fabry's disease Cystic fibrosis respiratory infection suppression More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Diagnostics CADASIL – Treatment Angiosarcoma recurrent – Basic Information Undifferentiated sarcoma – Treatment Gastrointestinal stromal tumour – Treatment Mitochondrial myopathy – Basic Information Nodal marginal zone B-cell lymphoma Marginal zone lymphoma – Trials in Disease Prolymphocytic leukaemia – Diagnostics Cholangitis sclerosing – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cinnarizine Dotatate Inupadenant HYDROGEN PEROXIDE SEVABERTINIB Vo659 Zenocutuzumab Triptorelin Pamoate Hydroxocobalamin Tolcapone 177Lu-Rhpsma-10.1 Raltegravir Vinflunine Palbociclib Folinic Acid Escitalopram Oxalate ALE1 Dasatinib EGANELISIB Vosoritide More therapies…

    Learn about Your Condition

    Medication overuse headache Brain neoplasm malignant Depression Drug eruption Pyrexia Small fibre neuropathy Henoch-Schonlein purpura Skin ulcer Mitral valve prolapse Glycogen storage disorder Follicular lymphoma stage IV Hyperplasia adrenal Haemorrhoids Psoriatic arthropathy Pulmonary resection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer

  • Study on Teverelix for Patients with Advanced Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Teverelix
    Lithuania

  • Study of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Abiraterone Acetate
    • Cabazitaxel
    • Xaluritamig
    Austria Belgium Denmark France Germany Greece +5

  • Study on the Safety and Feasibility of PSMA-T4 for Prostate Cancer Patients

    Not recruiting

    4 1 1
    Poland

  • Study on Radiometabolic Therapy with 177Lu-PSMA for Patients with Advanced or Metastatic Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 177LU-PSMA-I&T
    Italy

  • Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 18F-Psma-1007
    • Piflufolastat (18F)
    • Gozetotide
    The Netherlands

  • Study on the Use of 64Cu-PSMA I&T to Detect Lymph Node Spread in Men with Newly Diagnosed Prostate Cancer Before Surgery

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • 64CU-PSMA I&T
    France Italy Spain
Previous Page
1 … 8 9 10 11 12 … 17
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!